AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹60.02 | ₹54.16 | ₹32.90 | ₹45.20 | ₹91.05 |
What is the latest Earnings Per Share (EPS) of AUROBINDO PHARMA ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹60.02 |
| Mar2024 | ₹54.16 |
| Mar2023 | ₹32.90 |
| Mar2022 | ₹45.20 |
| Mar2021 | ₹91.05 |
How is Earnings Per Share (EPS) of AUROBINDO PHARMA Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹60.02 | 10.82 | |
| Mar2024 | ₹54.16 | 64.62 | |
| Mar2023 | ₹32.90 | -27.21 | |
| Mar2022 | ₹45.20 | -50.36 | |
| Mar2021 | ₹91.05 | - | |
Compare Earnings Per Share (EPS) of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹66,536.4 Cr | -2.3% | -6.4% | -4.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹392,147.0 Cr | -2.1% | -7.7% | -9.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,208.0 Cr | -2.6% | -6.8% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,190.0 Cr | 0.1% | 5.5% | 25.3% | Stock Analytics | |
| CIPLA | ₹110,790.0 Cr | -1.9% | -9.3% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,587.0 Cr | 3.5% | -5.2% | -11.8% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | -2.3% |
-6.4% |
-4.8% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses